Curriculum Vitae

Research Interest

Heart Failure, Cardiomyopathy, and Preventive Cardiology. Gregg C. Fonarow, M.D. serves as Director of the Ahmanson-UCLA Cardiomyopathy Center and is Director of UCLA's Cardiology Fellowship Program. His research interests center on heart failure management and implementing treatment algorithms to improve clinical outcome. Dr. Fonarow has published a number of research studies and clinical trials in heart failure management. New therapies and management strategies for advanced heart failure and research into the pathophysiology of this disease are conducted at UCLA under his direction. The UCLA Clinical Practice Guidelines for heart failure, acute myocardial infarction, atherosclerosis prevention and treatment, and unstable angina were authored by Dr. Fonarow. He has also developed and successfully implemented a comprehensive atherosclerosis treatment program at the UCLA Medical Center (Cardiac Hospitalization Atherosclerosis Management Program: CHAMP).

Representative Publications

Fonarow GC, French W, Malmgren J, Parsons L, Sun H. Utilization of lipid lowering medications at discharge in patients with acute myocardial infarction: Data from the National Registry of Myocardial Infarcation 3. Circulation 2001; 103:38-44.

Fonarow GC, Gawlinski A, Cardin S, Moughrabi S, Tillisch JH. Improved treatment of cardiovascular disease by implementation of a cardiac hospitalization atherosclerosis management program: CHAMP. Am J Cardiol 2001; 87:819-822.

Fonarow GC, Stevenson LW, Walden JA, Livingston NA, Steimle AE, Hamilton MA, Moriguchi JD, Tillisch JH, Woo MA. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 1997;30(3):725-733.

Fonarow GC, Wiener I, Feliciano Z, Knight L, Woo MA, Moriguchi JD, Boyle N, Laks H Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable defibrillator. Am J Cardiol, 2000, 85:981-85.

Fonarow GC, Ballantyne CM. In-hospital initiation of lipid lowering therapy for patients with coronary heart disease: the time is now. Circulation 2001; 103:2768-2770.

Fonarow GC. Heart failure: recent advances in prevention and treatment. Reviews in Cardiovascular Medicine. 2000;1:25-33.